J Biol Chem, Vol. 274, Issue 38, 26654-26660, September 17, 1999
The Yeast Hsp110 Family Member, Sse1, Is an Hsp90
Cochaperone*
Xiao-Dong
Liu
§,
Kevin A.
Morano
¶, and
Dennis J.
Thiele
From the Department of Biological Chemistry, University of Michigan
Medical School, Ann Arbor, Michigan 48109-0606
 |
ABSTRACT |
In eukaryotes, production of the diverse
repertoire of molecular chaperones during normal growth and in response
to stress is governed by the heat shock transcription factor HSF. The
HSC82 and HSP82 genes, encoding isoforms of the
yeast Hsp90 molecular chaperone, were recently identified as targets of
the HSF carboxyl-terminal activation domain (CTA), whose expression is
required for cell cycle progression during prolonged heat stress
conditions. In the present study, we have identified additional target
genes of the HSF CTA, which include nearly all of the heat
shock-inducible members of the Hsp90 chaperone complex, demonstrating
coordinate regulation of these components by HSF. Heat shock induction
of SSE1, encoding a member of the Hsp110 family of heat
shock proteins, was also dependent on the HSF CTA. Disruption of
SSE1 along with STI1, encoding an established
subunit of the Hsp90 chaperone complex, resulted in a severe synthetic
growth phenotype. Sse1 associated with partially purified Hsp90
complexes and deletion of the SSE1 gene rendered cells
susceptible to the Hsp90 inhibitors macbecin and geldanamycin,
suggesting functional interaction between Sse1 and Hsp90. Sse1 is
required for function of the glucocorticoid receptor, a model substrate
of the Hsp90 chaperone machinery, and Hsp90-based repression of HSF
under nonstress conditions. Taken together, these data establish Sse1
as an integral new component of the Hsp90 chaperone complex in yeast.
 |
INTRODUCTION |
Cells respond to a variety of environmental stresses by inducing
the heat shock response, the coordinated synthesis of a set of proteins
that protect the cell from damage and facilitate recovery (1, 2). In
eukaryotes, this response is primarily governed at the transcriptional
level by the heat shock transcription factor (HSF),1 a highly conserved
protein that binds to heat shock elements (HSEs), specific
cis-acting sequences upstream of genes encoding heat shock
proteins (Hsps). HSF is a modular protein composed of a highly
conserved amino-terminal DNA binding domain followed by a series of
hydrophobic heptad repeats that comprise the trimerization interface
for the active factor (3). In addition, all HSF molecules possess a
transcriptional activation domain in the carboxyl terminus that shows
low sequence conservation. In higher eukaryotes, multiple distinct HSF
isoforms exist that display differential specificity for HSE binding
and respond to diverse stimuli. In yeast, however, HSF is encoded by a
single essential gene, HSF1, which possesses both an
amino-terminal trans-activation domain and a
carboxyl-terminal trans-activation domain (CTA) (4, 5). The
two domains appear to be differentially used for target gene
activation, since expression of the copper metallothionein gene
CUP1 in response to heat, oxidative stress, or glucose
starvation is abolished when the CTA is deleted, while expression of at
least three other heat shock genes, SSA1, SSA3,
and SSA4, is largely unaffected (6-8). Deletion of either domain alone has little effect at normal growth temperatures, but cells
expressing HSF (1-583), a truncated form of HSF lacking the CTA, are
temperature-sensitive for growth at 37 °C (4, 5). The
temperature-sensitive phenotype is due to reversible arrest in the
G2/M phase of the cell cycle (9), a phenotype shared by two
other mutant alleles of HSF1, mas3 and
hsf1-82 (10, 11). Both HSF (1-583) and hsf1-82
mutants are defective in expression of the yeast Hsp90 genes
HSP82 and HSC82, and temperature-sensitive cell
cycle arrest can be partially suppressed by restoring cellular levels
of Hsp90, implying a role for this molecular chaperone in cell cycle
progression during stress (9, 11). However, depletion of Hsp90 levels
during growth at 37 °C in a wild type HSF background results in a
mixed population of G1/S and G2/M phase-arrested cells (9). Based on the incomplete suppression of HSF
(1-583) temperature sensitivity by HSP82, and the different cell cycle arrest phenotypes observed with HSF (1-583) or
Hsp90-depleted cells, it was proposed that other HSF gene targets might
be required for cell division during heat stress in addition to Hsp90
(9).
Hsp90 is a ubiquitous and abundant cytosolic chaperone first
characterized in the function and regulation of steroid hormone receptors (12), but the cast of substrate or "client" proteins has
grown to include proteins such as the cell cycle regulatory kinase Cdk4
(13), signal transduction kinases such as Raf and Src (14-17),
transcription factors such as Hap1 (18), HSF itself (19-21), the tumor
suppressor protein p53 (22), and recently the catalytic subunit of the
mammalian telomerase complex (23). Hsp90 associates with a number of
proteins required for full chaperone activity, and these individual
components are well conserved in eukaryotes (12, 24). In yeast, the
complex has been demonstrated to include Hsp70 and the cochaperone Ydj1
(25, 26), the Cyp-40 cyclophilin orthologs Cpr6 and Cpr7 (25, 27), the
p60 ortholog Sti1 (25, 28), Cdc37 (29), and the p23 ortholog Sba1 (30). The Hsp90 chaperone complex is dynamic, with distinct subunits associating at various stages of the folding/chaperoning process for
different client proteins (31). For example, during maturation of the
glucocorticoid receptor (GR), early complexes form, which include GR,
Hsp90, Hsp70, Ydj1, and p60. After hormone binding, the Hsp70/Ydj1 pair
dissociate, and p60 is replaced by the cyclophilin Cyp-40, probably
through competition for the single tetratricopeptide repeat binding
domain in Hsp90 (32, 33). p23 is frequently found associated with late
stage complexes immediately prior to substrate release (34). In
vitro, many of these purified subunits are capable of maintaining
substrate proteins in a folding competent state, which requires the
action of the Hsp70 and Ydj1 chaperones to achieve the final folded
conformation (29, 35, 36).
The Hsp70 superfamily of molecular chaperones is divided into three
subgroups based on sequence homology: the DnaK subfamily, the
GRP170/Lhs1 subfamily, and the Hsp110/Sse1 subfamily (37). All share a
high level of homology within their amino termini, which includes the
ATP-binding domain essential for catalytic folding activity, but
diverge within the carboxyl termini, thought to be responsible for
interaction with substrate proteins. The founding members of the
Hsp110/Sse1 subfamily are the SSE1 and SSE2 genes
from yeast, which show 76% identity with each other but only 30-40%
identity with the DnaK group of Hsp70s (38). The SSE1 and
SSE2 genes were first identified as calmodulin-binding proteins (38), and SSE1 was also isolated independently in a genetic study as MSI3, a multicopy suppressor of the heat
shock-sensitive phenotype of Ras-cAMP pathway hyperactivation (39).
However, the true functions of Sse1 and Sse2 in yeast are currently
unknown. While heat shock-induced proteins of approximately 110 kDa
have long been observed in higher eukaryotes, only recently have Hsp110 members from a variety of organisms including human, plant, nematode and fission yeast been cloned and found to share substantial homology (~40%) to the SSE1/SSE2 genes (40-45). Interestingly,
unlike Hsp70, the Hsp110 class of chaperones can maintain
heat-denatured proteins such as firefly luciferase in a
folding-competent state (46, 47).
In order to more precisely determine the cause of cell cycle arrest in
HSF (1-583) mutant cells, we sought to identify additional gene
products whose heat shock-induced expression was abrogated relative to
wild type cells. We demonstrate that expression of SSE1 is
dependent upon the HSF CTA. In addition, most of the heat shock-inducible components of the Hsp90 chaperone complex were found to
share this requirement, suggesting tight coordinate regulation of their
expression. Moreover, SSE1 displays synthetic genetic interactions with chaperone genes, is physically associated with purified Hsp90 complexes, and is required for Hsp90 activity in vivo. Together these findings identify Sse1 as a novel member of
the Hsp90 chaperone complex.
 |
EXPERIMENTAL PROCEDURES |
Plasmids--
In-frame fusion of the triple hemagglutinin (HA)
tag to the amino terminus of the SSE1 gene was accomplished
by insertion of annealed oligonucleotides encoding three repeats of the
HA epitope 3' of the initiator ATG codon. The fusion gene was cloned into the HIS3-based pRS313 vector to generate
pRS313-HA-SSE1. For disruption of the STI1 gene, the
oligonucleotides
5'-GAGCTCTTCACTAAAGCTATTGAAGTTTCTGAAACTCCAAACCATGTTTTATATTCTAACAGGTCCGCCTGTaagcttcgtacgctgcag-3' and
5'-TTCATGGCCCTTTGATAGGTTTCTTCTGGGGTTTCGTTACTGGTACCAGGTTGGAATCTTTGTTGGCTTGCCggccactagtggatctga-3' were used to amplify the KanMX2 cassette from the pFA-KanMX2
plasmid (48) by PCR. Uppercase letters represent sequences native to the STI1 gene. The PCR-amplified fragment contains 72 base
pairs of flanking sequences (both 5' and 3') that are homologous to the
STI1 gene. Approximately 4 µg of the PCR product was used to transform Saccharomyces cerevisiae cells, and
G418-resistant colonies were recovered. The SSE1 gene was
similarly disrupted by a PCR product amplified from the pFA-KanMX2
cassette using oligonucleotides
5'-GATGAGTACTCCATTTGGTTTAGATTTAGGTAACAATAACTCTGTCCTTGCCGTTGCTAGAAACAGAGGTATaagcttcgtacgctgcag-3' and
5'-GACCTTCTGGTAATTGAACACCAGTGATCTCCCAGTTAGCGATTTGTTCTGGAGTGTTTGGTGGTAACTGTGggccactagtggatctga-3'. The resulting strains carrying the appropriate disruptions were G418-resistant and displayed the expected phenotypes as described previously (48), and the mutated alleles were verified by PCR. p413GPD-rGR and pYRP-GRElacZ (a kind gift from D. McDonnell, Duke University) expressing rat glucocorticoid receptor and a
lacZ reporter construct containing GR-binding elements were
as described (9). YEp-STI1 was a kind gift from Elizabeth Craig
(University of Wisconsin) (49), and YEp-SSE1 was from Akio Toh-e
(University of Tokyo) (39). pCM64-SSA3-lacZ is as described (7).
Strains and Growth Conditions--
S. cerevisiae
strains used in this study are listed in Table
I. Cells were grown in synthetic complete
(SC) medium minus the indicated nutrients (SC-x) at 30 °C to midlog
phase (A650 = 0.7-1.4). For growth dilution
series assays, saturated liquid cultures were adjusted to approximately
1 × 106 cells/ml, serially diluted, and plated on
SC-x agar plates for incubation at 30 °C or 37 °C as indicated.
Sensitivity to the benzoquinoid ansamycins macbecin and geldanamycin
was assayed on YPD plates made by adding the drugs in Me2SO
to melted YPD agar solution to a final concentration of 35 µM. Macbecin was obtained from the Drug Synthesis and
Chemistry branch of NCI, National Institutes of Health. Geldanamycin
was obtained from Dr. William Pratt (University of Michigan Medical
School, Ann Arbor, MI). sse1
HSF (1-583) and
sti1
HSF (1-583) cells were generated from XLY24
(sse1
, GAL1-HSF) and XLY25 (sti1
, GAL1-HSF) strains, respectively. XLY24 and XLY25 were transformed with
HSF-(1-583)-expressing plasmids and grown to saturation in
galactose-containing medium (to allow for expression of GAL1-HSF). The
spot dilution assay was carried out as described above using SC agar
plates with glucose as sole carbon source to repress GAL1-HSF
production, causing HSF-(1-583) to be the only source of HSF. For heat
shock treatment, cells were grown at 25 °C to midlog phase, and 5 ml
of cells were either kept at 25 °C (control) or at 41 °C (heat
shock) for 16 min or 1 h (Fig. 6). Cells were then washed with
ice-cold sterile glass-distilled water and stored at
80 °C, prior
to extraction of RNA for RNA blotting experiments or proteins for
immunoblotting.
35S Protein Labeling--
Five ml of cells were
grown in SC-Met-Cys to early log phase, harvested, and resuspended in 1 ml of SC-Met-Cys. The cultures were incubated at 23 or 41 °C for 15 min with constant agitation and then transferred to prewarmed Eppendorf
microcentrifuge tubes each containing 158 µCi of
Tran35S-labelTM (ICN, CA). The tubes were
further incubated for another 15 min at 23 or 41 °C. Cells were than
washed once with ice-cold sterile glass-distilled H2O, and
the pellet was frozen at
80 °C. Cell extracts were prepared as
described below, and scintillation counting to determine total
incorporation of label was carried out on a Beckman LS6500
scintillation counter (Beckman Instruments). Equivalent cpm of extracts
were fractionated with SDS-PAGE (8%) using a Hoeffer gel
electrophoresis system (SE400 model) at 4 °C. The gel was rinsed in
glass-distilled H2O for 15 min, incubated in
AutoFluorTM (National Diagnostics, Inc.) for 30 min at room
temperature, vacuum-dried, and exposed to Kodak BioMax film at
80 °C. A Molecular Dynamics PhosphorImager system was used for
quantitative assessment of labeled protein levels.
Immunoblot Analysis--
Cell pellets containing between 5 and
15 A650 units of cells were resuspended in HEGN
buffer (20 mM HEPES, pH 7.9, 1 mM EDTA, 10%
glycerol, 50 mM NaCl) or SDS harvest buffer (0.5% SDS, 10 mM Tris-HCl at pH 7.4, 1 mM EDTA), with the
following protease inhibitors added: 1 mM PefablocTM
(Roche Molecular Biochemicals), 8 µg/ml aprotinin, 4 µg/ml
pepstatin, 2 µg/ml leupeptin. After the addition of an equal volume
of acid-washed sterile glass beads (450-600 µm), the samples were
lysed by rapid agitation at 4 °C in a microtube mixer (model MT-360;
Tomy Tech, Inc.) at top speed for 2 min for four cycles with 2-min
intervals on ice between each round. Extracts were clarified by
microcentrifugation at 2500 × g for 6 min at 4 °C,
and protein concentration was determined by Bradford assay. The
extracts were fractionated by SDS-PAGE (8%), and electroblotted to
nitrocellulose. Standard immunoblot procedures were used, followed by
protein detection using the ECL chemiluminescence system according to
the manufacturer's instructions (Amersham Pharmacia Biotech).
Monoclonal antibody recognizing phosphoglycerate kinase was purchased
from Molecular Probes, Inc. (Eugene, OR), and the following antibodies
were generous gifts from the following sources: Anti-Ssa3/Ssa4 from
Elizabeth Craig (University of Wisconsin, Madison, WI); anti-hsp90 from
Susan Lindquist (University of Chicago); anti-Ydj1 from Avrom Caplan (Mt. Sinai School of Medicine); anti-Sti1 from David Toft (Mayo Graduate School); anti-Cpr7 from Richard Gaber (Northwestern
University); anti-Kar2 from James Gaut (University of Michigan Medical School).
Affinity Purification of Hsp90 Complexes--
Lysates were
prepared from cells (XLY34 and XLY30) grown to midlog phase in SC-His
medium at 30 °C in LyB buffer (25), using similar procedures as
described above for immunoblot analysis. Isolation of
His6-Hsp82 and associated polypeptides with nickel affinity
chromatography was carried out exactly as described (25).
-Galactosidase Activity Assay for GR Function--
Five ml of
cells transformed with p413GPD-rGR and pYRP-GRElacZ were grown to
midlog phase in SC-Ura-His medium at 30 °C, and 5 µl of absolute
ethanol (control) or 10 mM DOC (deoxycorticosterone; Sigma)
dissolved in ethanol were added to the cell culture (final concentration of 10 µM). The cells were further incubated
with shaking at 30 °C for 1 h, harvested, washed once with
sterile glass-distilled H2O, and resuspended in 700 µl of
Z buffer (100 mM sodium phosphate, pH 7.0, 10 mM KCl, 1 mM MgSO4, 50 mM
-mercaptoethanol). 50 µl of chloroform and 50 µl
of 0.1% SDS were added, and the cell suspension was vortex-mixed at
top speed for 10 s followed by incubation at 30 °C for 5 min.
200 µl of 4 mg/ml ONPG in Z buffer was added to each sample and
incubated at 30 °C for 3-7 min. 350 µl of 1 M
Na2CO3 was added to stop the reactions. After clarification by centrifugation, the supernatant was diluted, and
A420 was measured within the linear response
range. Specific
-galactosidase activity was calculated as follows:
(dilution factor × 1000 × A420)/(A650 × (volume of
cells in ml) × (time of incubation in min)). Data shown are
averages of three independent experiments with associated S.D.
 |
RESULTS |
The HSF Carboxyl-terminal Activation Domain Regulates Expression of
a Subset of the Heat-inducible Components of the Hsp90 Chaperone
Complex--
Previous work has demonstrated that expression of the two
yeast Hsp90 genes HSC82 and HSP82 is markedly
reduced in a strain expressing the HSF truncation mutant HSF (1-583),
which displays a temperature-sensitive growth phenotype characterized
by arrest in the G2/M phase of the cell cycle (9). Two
points, however, suggest that loss of Hsp90 is not the sole determinant
of this arrest. First, restoration of Hsp90 levels through introduction of the HSP82 gene on a high copy vector does not lead to
growth rates at 37 °C comparable with wild type cells. Second,
specific depletion of Hsp90 from cells wild type for HSF results in a
mixed population of cells arrested in both the G1/S and
G2/M phases of the cell cycle at 37 °C, in contrast to
the fairly uniform G2/M arrest observed in HSF (1-583).
Therefore, we reasoned that there must be additional genes under the
specific control of the HSF CTA that are required for growth at higher
temperatures and that are poorly expressed in HSF-(1-583) cells.
To begin to identify these additional targets, SDS-PAGE protein
profiles of 35S pulse-labeled HSF and HSF (1-583) cell
extracts was conducted under control and heat shock conditions (Fig.
1A). Heat shock induces the
synthesis of a number of known Hsps, whose SDS-PAGE migration patterns
have been well documented (50). We were able to faithfully recapitulate
these patterns, demonstrating robust heat shock induction of a number
of proteins, including Hsp104 and the Hsp70 isoforms Ssa1, Ssa3, and
Ssa4. Three proteins whose heat shock inducibility was diminished in
HSF (1-583) cells compared with HSF wild type were tentatively
identified (Fig. 1A, bands a-c) by
comparison with published heat shock protein profiles (39, 50).
Consistent with our previous results, band a was likely to be the unresolved Hsp90 isoforms Hsc82 and Hsp82p,
band b corresponded to the Hsp70 homolog Sse1,
and band c was consistent with the known
positions of the heat shock proteins Kar2 and Sti1, which co-migrated
in this SDS-PAGE system. Immunoblotting was carried out to
unambiguously ascertain expression levels of these putative targets in
wild type or HSF (1-583) cells, as shown in Fig. 1B. Kar2
expression was unchanged in both strains, similar to Ssa3 and Ssa4,
whose heat shock induction has been previously demonstrated to be HSF
CTA-independent (6, 7). However, both the basal and heat shock-induced
expression levels of Sti1, a key component of the Hsp90 chaperone
complex, were strongly dependent on the HSF CTA. The finding that two
heat shock-inducible components of the Hsp90 chaperone complex, Hsp90
and Sti1, were both regulated by the HSF CTA prompted us to examine
other known heat-inducible components of the complex. Immunoblotting
revealed that Ydj1 is indeed a third member of the chaperone complex
whose expression is contingent on the HSF CTA (Fig. 1B). In
addition, it was recently reported that the gene encoding the yeast
Cyp-40 homolog Cpr6 was also highly heat-inducible (51); our RNA blot analysis confirmed this heat inducibility and demonstrated that this
induction is abolished in HSF (1-583) cells (Fig. 1C).
Expression of the other Cyp-40 homolog Cpr7 is not heat-inducible, nor
is its constitutive expression HSF CTA-dependent (data not
shown). The expression of two other Hsp90-associated proteins, the p23 homolog Sba1 and the protein kinase cochaperone Cdc37, have been reported not to change upon heat shock. Therefore, all of the heat-inducible components of the Hsp90 chaperone complex, with the
exception of the cytosolic Hsp70 proteins, depend on the HSF CTA for
expression at elevated temperature. To verify that the reduction in
signal intensity of band b in HSF (1-583) cells
corresponded to a lack of transcriptional induction of the
SSE1 gene, RNA blotting was used due to lack of antibody
against Sse1 and was compared with STI1 RNA levels (Fig.
1C). Changes in STI1 transcript levels upon heat
shock in wild type and HSF (1-583) cells closely paralleled Sti1
protein expression levels, emphasizing the strict transcriptional control of this gene product. SSE1 mRNA was moderately
induced by heat shock, and this induction was largely abolished in HSF (1-583) cells, concomitant with a reduction in basal expression. Therefore, in addition to the copper metallothionein Cup1, the heat-inducible expression of five additional proteins requires the HSF
CTA: Hsp82, Sti1, Ydj1, Cpr6, and Sse1.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
The HSF CTA regulates expression
of the Hsp90 chaperone complex. A, the HSF CTA is
required for heat shock-inducible synthesis of a subset of heat shock
proteins. Cells harboring wild type HSF or HSF-(1-583) were grown in
SC-Met-Cys medium at 25 °C, maintained at 25 °C (C) or
heat-shocked at 41 °C for 15 min (HS), and pulse-labeled
with 35S-Trans-labelTM for another 15 min under
the same conditions. The cell extracts were fractionated by SDS-PAGE
(8%) and exposed to film. Bands a-c correspond
to proteins whose heat shock-inducible synthesis is lower in the
HSF-(1-583) strain. B, the HSF CTA regulates the production
of Sti1 and Ydj1 in addition to Hsp90. Immunoblotting was performed on
cell extracts prepared from wild type HSF or HSF-(1-583) cells grown
under heat shock (41 °C) or control (25 °C) conditions for 1 h. Phosphoglycerate kinase (PGK) is the loading control.
C, CPR6 and SSE1 gene expression also
requires the HSF CTA. mRNA levels of SSE1 and
STI1 were assessed by RNA blotting, using RNA extracted from
wild type HSF or HSF-(1-583) cells grown under heat shock (41 °C)
or control (25 °C) conditions for 16 min.
|
|
SSE1 Displays Genetic Interactions with the Hsp90 Chaperone Complex
Subunit STI1--
The composition and function of the Hsp90 chaperone
complex is highly conserved from yeast to humans, and it is required
for maturation and functional maintenance of a number of key cellular regulatory proteins. Nearly half of its known components show heat-inducible synthesis (Hsp90, Sti1, Ydj1, and Cpr6p), suggesting a
higher demand for chaperone function at heat shock temperatures, during
which protein structure and function are compromised. The fact that
Hsp90, Sti1, Ydj1, and Cpr6 expression are all regulated by the HSF CTA
further supports our previous hypothesis that the temperature
sensitivity of cells harboring HSF (1-583) is largely due to
inadequate levels of the Hsp90 chaperone complex at 37 °C. In
keeping with the close functional affiliation of the protein subunits,
many of the genes encoding the cochaperones exhibit strong synthetic
genetic interactions with STI1. For example, although
deletion of the STI1 gene does not cause an obvious growth defect at 30 °C, disruption of STI1 along with
CPR7, SBA1, or HSC82 results in severe
growth impairment (27, 28, 30). To ascertain if low levels of Hsp90
chaperone activity rendered HSF-(1-583) cells sensitive to additional
perturbation of the Hsp90 complex, a strain was generated carrying a
disruption of the STI1 gene in the presence of the HSF
(1-583) allele. As shown in Fig.
2A, HSF (1-583),
sti1
, or sse1
mutant strains exhibited relatively normal growth at 30 °C compared with wild type cells; however, the combination of sti1
and HSF (1-583)
resulted in a synthetic phenotype, drastically reducing cell viability
and growth rates. The lack of obvious growth defects of HSF-(1-583) cells at 30 °C suggests that although HSF CTA truncation lowers basal level expression of Hsp90, Sti1, and Ydj1 (Fig. 1B),
the residual chaperone activity is sufficient under these growth
conditions. However, complete elimination of Sti1 by gene disruption
caused a severe growth defect in HSF (1-583) cells even at 30 °C,
consistent with Sti1 playing an important role in Hsp90 chaperone
function, especially when Hsp90 levels are limiting. Interestingly,
when HSF (1-583) cells were deleted for SSE1, a phenotype similar to sti1
HSF (1-583) was observed (Fig. 2A).
Additional evidence for genetic interaction was obtained by combining
the sti1
and sse1
mutations, as shown in
Fig. 2B. While disruption of either gene alone had little
effect at 30 °C, a sti1
sse1
strain displayed moderate growth inhibition, which was exacerbated at 37 °C. The synthetic phenotype obtained by combining the sti1
and
sse1
mutations implies that the presence of at least one
of the two proteins is critical for cell growth. However, Sti1 and Sse1
are not functionally redundant, since high copy expression of the SSE1 gene not only failed to rescue the slight growth
disadvantage of sti1
cells but in fact further
debilitated cell growth, as assayed in a dilution series on solid
medium and by growth rates in liquid culture (Fig. 2C).
These genetic data suggest that like Sti1, Sse1 function may also be
affiliated with the Hsp90 complex or is redundant with Hsp90 function
in an alternative pathway.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 2.
SSE1 genetically interacts with
STI1, encoding a component of the Hsp90 chaperone
complex. A, deletion of the SSE1 gene
exhibits a synthetic phenotype with HSF (1-583). Isogenic NSY-A
(WT), NSY-B (HSF (1-583)), XLY18
(sse1 ), XLY19 (sti1 ) strains and strains
harboring either sse1 HSF (1-583) or sti1 HSF
(1-583) (see "Experimental Procedures") were grown to
saturation. Equivalent cell concentrations were serially diluted and
plated on SC agar. The plate was incubated at 30 °C for 2 days and
photographed. B, isogenic DS10 (WT), CN11
(sti1 ), XLY35 (sse1 ), and XLY36
(sti1 sse1 ) strains were grown to saturation, and
serial dilutions of the cells were plated on SC agar, incubated for 2 days, and photographed. C, the strain XLY29
(sti1 ) was transformed with YEpSTI1, YEpSSE1, or YEp24
alone. The transformed cells were plated on SC agar plates as in
A. Growth rates (doubling times) were derived from the
exponential range of replicate growth curves of the corresponding
strains in liquid culture at 30 °C.
|
|
Sse1 Is a Component of the Hsp90 Complex Required for Chaperone
Function--
The coincident heat shock regulation and genetic
interaction with components of the Hsp90 chaperone complex suggested
that Sse1 may directly participate in Hsp90 chaperone complex function. Biochemical purification of Hsp90 and associated proteins from native
cell extracts has been successful in identifying new components of the
chaperone complex, including Sti1, Cpr6, and Cpr7 (25, 27). The
possibility that Sse1 may also be a component of the complex was
investigated by affinity chromatography of Hsp90 complexes containing a
polyhistidine-tagged Hsp82 (His6-Hsp82p), previously shown
to be fully functional in yeast (25). Cells expressing a plasmid-borne
His6-Hsp82 or an unmodified wild type Hsp82 as the sole
source of Hsp90 (the endogenous HSP82 and HSC82
genes were deleted) and expressing a triple HA-tagged Sse1 (HA-SSE1) in
place of the endogenous SSE1 gene were used to purify the
Hsp90 chaperone complex (HA-Sse1 was demonstrated to be largely
functional based on complementation of the sse1
growth
defect, data not shown). A metal chelation affinity matrix was used to
selectively isolate His6-Hsp82 and associated proteins. As
shown in Fig. 3, Sti1, Ydj1, and Cpr7,
known components of the complex, co-purified with
His6-Hsp82 (lanes 2 and
3), as did HA-Sse1. Selective enrichment of Hsp90-associated
proteins was demonstrated by the lack of binding of the abundant
cytosolic enzyme phosphoglycerate kinase. A small amount of nonspecific
binding of all of the assayed proteins to the affinity matrix alone
(lane 6) was observed, which could be eluted with
SDS-PAGE sample buffer but not the more specific imidazole elution
buffer, and was negligible compared with that observed with the
His6-Hsp82 in lane 3. This specific
interaction of Sse1 with Hsp90 in native cell extracts strongly
suggested that it may play a functional role with Hsp90 in
vivo. This hypothesis was tested by examining whether loss of Sse1
affected the ability of cells to tolerate the benzoquinoid ansamycins
macbecin and geldanamycin. These closely related compounds have been
demonstrated to selectively bind and inhibit the chaperone activity and
signal transduction functions of Hsp90 (52, 53). Both drugs strongly inhibit Hsp90-dependent steroid hormone receptor activity
in yeast (9, 54), and geldanamycin is cytotoxic to cells compromised for Hsp90 function by reduction of Hsp90 levels or deletion of Hsp90-associated cochaperones (9, 51). As demonstrated in Fig.
4, whereas wild type cell growth was
unaffected by the presence of either Hsp90 inhibitor, the growth of
sti1
cells, and to a lesser extent sse1
cells, was strongly inhibited. Residual colony formation observable in
sti1
cells was completely abolished in the sti1
sse1
mutant strain, consistent with the synthetic growth phenotype observed at 37 °C in Fig. 2. Interestingly, geldanamycin was slightly more cytotoxic at the same concentration (35 µM) than macbecin, consistent with earlier findings that
the former compound was more efficacious in inhibition of steroid
hormone receptor signaling in yeast (54).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 3.
Sse1 physically associates with the Hsp90
chaperone complex. Cell extracts were prepared from XLY30
(His6-Hsp82, HA-SSE1) and XLY34 (Hsp82, HA-SSE1) strains
grown at 30 °C to midlog phase as described under "Experimental
Procedures." The cell extracts were incubated with a Ni2+
affinity resin and washed, and the bound fraction was eluted with 150 mM imidazole (E). The posteluted resin was
boiled in SDS sample buffer to solubilize remaining proteins
(SDS). A portion of the total cell extract was also included
to verify the presence of the immunoblotted proteins prior to batch
chromatography (WCE). All fractions were resolved by
SDS-PAGE (8%) and subjected to immunoblotting with the corresponding
antibodies (anti-HA monoclonal Ab 12CA5 was used to visualize
HA-Sse1p).
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
sse1 cells are hypersensitive to
Hsp90 inhibitors. Equivalent cell concentrations of isogenic DS10
(WT), CN11 (sti1 ), XLY35 (sse1 ),
and XLY36 (sti1 sse1 ) strains were serially diluted and
plated on YPD agar containing no drug or containing 35 µM
geldanamycin or macbecin. The plates were incubated in the dark at
30 °C for 2 days and photographed.
|
|
To further explore the role of Sse1 in Hsp90 function, we examined
whether Sse1 was required for function of the mammalian glucocorticoid
receptor (GR) expressed in yeast cells, a benchmark of Hsp90 chaperone
activity.
-Galactosidase activity from a GRE-lacZ reporter gene was used to assay for the trans-activation
function of GR upon stimulation with the synthetic hormone
deoxycorticosterone (DOC) (Fig.
5). A strong
hormone-dependent activation of GR was obtained in wild
type cells. However, GR activity was markedly reduced in
sse1
cells to an extent indistinguishable from that observed in cells lacking Sti1, which is required for full
Hsp90-chaperoned GR activity (28). Importantly, the effect of Sti1
deletion, and presumably Sse1 deletion, on GR activity is mediated
solely through Hsp90, as demonstrated by robust hormone-independent
transactivation by a GR derivative lacking the Hsp90 interaction domain
expressed in sti1
cells (28). To determine if loss of
Sse1 had a functional consequence for a physiologically relevant role
of Hsp90 in yeast, the ability of sse1
cells to restrain
the transcriptional activation of heat shock genes by HSF was examined.
Recent reports have established that the Hsp90 chaperone complex
negatively regulates HSF activity both in vitro and in
vivo (19-21), effectively holding HSF in check under nonstress
conditions. Deletion of SSE1 resulted in a 9-fold derepression of HSF activity under control conditions, demonstrated by
a reporter gene consisting of the lacZ gene fused to the
promoter of the heat-inducible yeast Hsp70 gene SSA3 (Fig.
6A). In contrast the
derepression observed in the sti1
strain was marginal,
consistent with previous reports demonstrating differential effects of
chaperone mutations on HSF regulation (19). Mutation of the HSE
sequences in the SSA3-lacZ reporter abolished
both the heat shock induction and basal activity, confirming that HSF
was solely responsible for reporter induction (data not shown). In
addition, HSF deregulation in the sse1
strain was also
manifest as a dramatic increase in steady state levels of the
endogenous Ssa3/Ssa4 proteins as detected by immunoblot analysis (Fig.
6B). These observations indicate that Sse1 is an important
component of the Hsp90 chaperone complex required for repression of HSF
basal activity. Taken together, these results provide compelling
genetic and biochemical evidence for a functional role for Sse1, a
previously uncharacterized heat shock protein, in the Hsp90 chaperone
complex. Moreover, production of this complex is coupled with demand in
response to thermal stress at the transcriptional level via a dedicated
trans-activation domain of HSF.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Sse1 is required for glucocorticoid receptor
function. p413GPD-rGR and pYRP-GRElacZ were transformed into
isogenic strains NSY-A (WT), XLY18 (sse1 ), and
XLY19 (sti1 ). Cells were grown to midlog phase at
30 °C and treated with 10 µM deoxycorticosterone
(DOC) in ethanol (+) or treated with ethanol alone ( ) for
1 h, and -galactosidase activities were measured as described
under "Experimental Procedures." The averages of three independent
experiments with associated S.D. values are shown. A diagram
depicting critical steps in Hsp90-mediated activation of GR by hormone
is shown at left.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Sse1 is required for repression of HSF basal
activity. A, pCM64-SSA3-lacZ was transformed into
isogenic DS10 (WT), CN11 (sti1 ), XLY35
(sse1 ), and XLY36 (sti1 sse1 ) strains.
The cells were grown to midlog phase at 30 °C and maintained at
30 °C or heat-shocked at 39 °C for 1 h, and
-galactosidase activities were measured. B, protein
extracts from the same cells as in A were resolved by
SDS-PAGE and immunoblotted for Ssa3/Ssa4 protein levels.
|
|
 |
DISCUSSION |
This study has revealed an intriguing coordinate regulation of the
heat-inducible components of the Hsp90 chaperone complex by the HSF
CTA: Hsp82, Sti1, Ydj1, Cpr6, and Sse1. This observed co-regulation
strongly supports an hypothesis put forward previously to explain the
incomplete suppression of the temperature-sensitive cell cycle arrest
phenotype of HSF-(1-583) cells by high copy HSP82 alone:
that other critical targets of the HSF CTA fail to be induced in this
strain in response to heat stress (9). It is also consistent with a
proposed higher requirement for Hsp90 chaperone complex function for a
select group of proteins at elevated temperatures (55). Co-regulation
at the transcriptional level ensures efficient and synchronized
increase of chaperone activity in response to stress, preventing a
potentially deleterious stoichiometric imbalance of subunits. The
observed regulation of the Hsp70 genes provides an interesting
exception to this rule. Six genes have been identified in yeast
encoding cytosolic Hsp70s, SSA1-SSA4, SSB1, and
SSB2, and it is not yet clear which of these participate in
Hsp90 chaperone complex function. Moreover, while SSA1,
SSA3, and SSA4 are highly heat shock-inducible,
SSA2, SSB1, and SSB2 are expressed at relatively
high basal levels and are involved in a number of Hsp90-independent
processes, such as translation (Ssb) and post-translational
translocation (Ssa) of proteins (56, 57). These considerations,
together with the apparent insensitivity of SSA1,
SSA3, and SSA4 heat shock induction to HSF CTA
truncation, are consistent with the notion that distinct
transcriptional control patterns are dictated by the two HSF
transcriptional activation domains.
By both genetic and biochemical criteria, we have identified Sse1 as a
novel component of the Hsp90 chaperone complex. SSE1 along
with a close homolog, SSE2, are both members of the Hsp70 superfamily of molecular chaperones, distant relatives of the family
archetype DnaK, and are the founding members of the Hsp110 subfamily of
Hsp70. Members of the Hsp110 family have been identified in multiple
species in addition to S. cerevisiae, including
Schizosaccharomyces pombe, Arabidopsis thaliana, Caenorhabditis
elegans, Neurospora crassa, and mammals, and they have been found
to be up-regulated by a number of stresses including heat (40-45). In
yeast, the SSE1 gene is expressed at moderately high levels
during normal growth and is further induced upon heat shock, while
SSE2 transcripts are undetectable until a more than 20-fold
induction following heat shock (38, 39). Disruption of SSE1
results in a slow growth phenotype at normal temperature, and cell
growth at 37 °C is extremely slow or completely stopped (Refs. 38
and 39; this work). In contrast, sse2
cells display no
obvious growth phenotype at 30 or 37 °C, nor does the
sse2
mutation exacerbate the sse1
growth
defect (38). Heat inducibility of SSE2 mRNA is not
appreciably affected by HSF CTA truncation, similar to that of
KAR2 (data not shown). Despite the sequence similarity between SSE1 and SSE2, we believe that by these
criteria, Sse1 is likely to be primarily involved in Hsp90 chaperone
function, especially at normal growth temperature where SSE2
is not expressed.
What is the role of Sse1 in protein folding by the Hsp90 complex? Sse1
was first identified as a calmodulin-binding protein (38), and
interestingly, murine Hsp90 also binds calmodulin, and the binding
domain has been mapped (58), leading to the hypothesis that the
calmodulin-binding ability of these two proteins may actually reflect
association of the chaperone complex with calmodulin, a calcium-binding
protein involved in signal transduction. It has recently been shown
that although possessing little protein folding activity by itself,
hamster Hsp110 associates with unfolded proteins in vitro
and blocks aggregation, with substantial renaturation of substrate
proteins upon the addition of Hsc70 and Hdj1 (46). Likewise, purified
Sse1 was recently reported to maintain denatured firefly luciferase in
a folding competent state prior to the addition of concentrated yeast
cytosol (47). Interestingly, the ability to maintain proteins in a
folding-competent state is a hallmark of Hsp90 and some Hsp90
cochaperones, including Cyp-40, p23, and Cdc37 (29, 35, 36), unlike the
Hsp70/DnaJ chaperones, which do not share this catalytic property. This
finding suggests that the Hsp110 subfamily is apparently functionally
distinct from the classical DnaK-like Hsp70 subfamily including
mammalian Hsp70, Hsc70, and the yeast Hsp70 proteins and probably plays
different roles than Hsp70 in the Hsp90 chaperone complex. Attempts at
demonstrating functional complementation of sse1
cells by
mammalian Hsp110 cDNA clones were unsuccessful (data not shown),
perhaps suggesting some degree of functional divergence within the
eukaryotic Hsp110 family or incomplete conservation of partner protein
interactions. Given the sophisticated in vitro systems
developed for Hsp90 chaperone function, it will be of considerable
interest to learn whether Hsp110 homologs in other eukaryotic systems
also function within the context of the Hsp90 chaperone complex.
 |
ACKNOWLEDGEMENTS |
We thank Dr. William Pratt, Dr. Phillip
C. C. Liu, and Nicholas Santoro for comments on the manuscript. We
gratefully acknowledge Drs. Susan Lindquist, Elizabeth Craig, Richard
Gaber, Avrom Caplan, John Subjeck, James Gaut, David Toft, and Jeffery
Brodsky for generously providing materials. We thank Chen Kuang for
technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by the Taisho Excellence in
Research Program, Taisho Pharmaceuticals Co., Ltd.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
Supported by a University of Michigan Rackham Predoctoral Fellowship.
¶
Supported by postdoctoral fellowships from the Cancer Biology
Training Program at the University of Michigan Comprehensive Cancer
Center (National Institutes of Health (NIH) Grant 5T32CA09676-06) and
NIH Grant 1F32 GM19195-01.
A Burroughs Wellcome Toxicology Scholar. To whom
correspondence should be addressed. Tel.: 734-763-5717; Fax:
734-763-7799; E-mail: dthiele@umich.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
HSF, heat shock
factor;
HSP, heat shock protein;
HSE, heat shock element;
CTA, carboxyl-terminal transcriptional activation domain;
HA, hemagglutinin;
GR, glucocorticoid receptor;
PCR, polymerase chain reaction;
SC, synthetic complete;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Feige, U., Morimoto, R. I., Yahara, I., and Polla, B. S.
(eds)
(1996)
Stress-inducible Cellular Responses
, Vol. 77
, Birkhauser Verlag, Basel
|
| 2.
|
Morimoto, R. I., Tissieres, A., and Georgopoulos, C.
(eds)
(1994)
The Biology of Heat Shock Proteins and Molecular Chaperones
, Cold Spring Harbor Laboratory, Plainview, Cold Spring Harbor, NY
|
| 3.
|
Wu, C.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
441-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Sorger, P. K.
(1990)
Cell
62,
793-805[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Nieto-Sotelo, J.,
Wiederrecht, G.,
Okuda, A.,
and Parker, C. S.
(1990)
Cell
62,
807-817[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Tamai, K. T.,
Liu, X.,
Silar, P.,
Sosinowski, T.,
and Thiele, D. J.
(1994)
Mol. Cell. Biol.
14,
8155-8165[Abstract/Free Full Text]
|
| 7.
|
Santoro, N.,
Johansson, N.,
and Thiele, D. J.
(1998)
Mol. Cell. Biol.
18,
6340-6352[Abstract/Free Full Text]
|
| 8.
|
Liu, X.-D.,
and Thiele, D. J.
(1996)
Genes Dev.
10,
592-603[Abstract/Free Full Text]
|
| 9.
|
Morano, K. A.,
Santoro, N.,
Koch, K. A.,
and Thiele, D. J.
(1999)
Mol. Cell. Biol.
19,
402-411[Abstract/Free Full Text]
|
| 10.
|
Smith, B. J.,
and Yaffe, M. P.
(1991)
Mol. Cell. Biol.
11,
2647-2655[Abstract/Free Full Text]
|
| 11.
|
Zarzov, P.,
Boucherie, H.,
and Mann, C.
(1997)
J. Cell Sci.
110,
1879-1891[Abstract]
|
| 12.
|
Pratt, W. B.
(1998)
Proc. Soc. Exp. Biol. Med.
217,
420-434[Abstract]
|
| 13.
|
Stepanova, L.,
Leng, X.,
Parker, S. B.,
and Harper, J. W.
(1996)
Genes Dev.
10,
1491-1502[Abstract/Free Full Text]
|
| 14.
|
Xu, Y.,
and Lindquist, S.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7074-7078[Abstract/Free Full Text]
|
| 15.
|
Dey, B.,
Lightbody, J. J.,
and Boschelli, F.
(1996)
Mol. Biol. Cell
7,
1405-1417[Abstract]
|
| 16.
|
van der Straten, A.,
Rommel, C.,
Dickson, B.,
and Hafen, E.
(1997)
EMBO J.
16,
1961-1969[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Silverstein, A. M.,
Grammatikakis, N.,
Cochran, B. H.,
Chinkers, M.,
and Pratt, W. B.
(1998)
J. Biol. Chem.
273,
20090-20095[Abstract/Free Full Text]
|
| 18.
|
Zhang, L.,
Hach, A.,
and Wang, C.
(1998)
Mol. Cell. Biol.
18,
3819-3828[Abstract/Free Full Text]
|
| 19.
|
Duina, A. A.,
Kalton, H. M.,
and Gaber, R. F.
(1998)
J. Biol. Chem.
273,
18974-18978[Abstract/Free Full Text]
|
| 20.
|
Zou, J.,
Guo, Y.,
Guettouche, T.,
Smith, D. F.,
and Voellmy, R.
(1998)
Cell
94,
471-480[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Ali, A.,
Bharadwaj, S.,
O'Carroll, R.,
and Ovsenek, N.
(1998)
Mol. Cell. Biol.
18,
4949-4960[Abstract/Free Full Text]
|
| 22.
|
Whitesell, L.,
Sutphin, P. D.,
Pulcini, E. J.,
Martinez, J. D.,
and Cook, P. H.
(1998)
Mol. Cell. Biol.
18,
1517-1524[Abstract/Free Full Text]
|
| 23.
|
Holt, S. E.,
Aisner, D. L.,
Baur, J.,
Tesmer, V. M.,
Dy, M.,
Ouellette, M.,
Trager, J. B.,
Morin, G. B.,
Toft, D. O.,
Shay, J. W.,
Wright, W. E.,
and White, M. A.
(1999)
Genes Dev.
13,
817-826[Abstract/Free Full Text]
|
| 24.
|
Johnson, J. L.,
and Craig, E. A.
(1997)
Cell
90,
201-204[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Chang, H. C.,
and Lindquist, S.
(1994)
J. Biol. Chem.
269,
24983-24988[Abstract/Free Full Text]
|
| 26.
|
Kimura, Y.,
Yahara, I.,
and Lindquist, S.
(1995)
Science
268,
1362-1365[Abstract/Free Full Text]
|
| 27.
|
Duina, A. A.,
Chang, H. C.,
Marsh, J. A.,
Lindquist, S.,
and Gaber, R. F.
(1996)
Science
274,
1713-1715[Abstract/Free Full Text]
|
| 28.
|
Chang, H. C.,
Nathan, D. F.,
and Lindquist, S.
(1997)
Mol. Cell. Biol.
17,
318-325[Abstract]
|
| 29.
|
Kimura, Y.,
Rutherford, S. L.,
Miyata, Y.,
Yahara, I.,
Freeman, B. C.,
Yue, L.,
Morimoto, R. I.,
and Lindquist, S.
(1997)
Genes Dev.
11,
1775-1785[Abstract/Free Full Text]
|
| 30.
|
Fang, Y.,
Fliss, A. E.,
Rao, J.,
and Caplan, A. J.
(1998)
Mol. Cell. Biol.
18,
3727-3734[Abstract/Free Full Text]
|
| 31.
|
Pratt, W. B.,
and Toft, D. O.
(1997)
Endocr. Rev.
18,
306-360[Abstract/Free Full Text]
|
| 32.
|
Young, J. C.,
Obermann, W. M.,
and Hartl, F. U.
(1998)
J. Biol. Chem.
273,
18007-18010[Abstract/Free Full Text]
|
| 33.
|
Prodromou, C.,
Siligardi, G.,
O'Brien, R.,
Woolfson, D. N.,
Regan, L.,
Panaretou, B.,
Ladbury, J. E.,
Piper, P. W.,
and Pearl, L. H.
(1999)
EMBO J.
18,
754-762[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Chen, S.,
Sullivan, W. P.,
Toft, D. O.,
and Smith, D. F.
(1998)
Cell Stress Chaperones
3,
118-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Freeman, B. C.,
Toft, D. O.,
and Morimoto, R. I.
(1996)
Science
274,
1718-1720[Abstract/Free Full Text]
|
| 36.
|
Freeman, B. C.,
and Morimoto, R. I.
(1996)
EMBO J.
15,
2969-2979[Medline]
[Order article via Infotrieve]
|
| 37.
|
Craven, R. A.,
Tyson, J. R.,
and Stirling, C. J.
(1997)
Trends Cell Biol.
7,
277-282[Medline]
[Order article via Infotrieve]
|
| 38.
|
Mukai, H.,
Kuno, T.,
Tanaka, H.,
Hirata, D.,
Miyakawa, T.,
and Tanaka, C.
(1993)
Gene (Amst.)
132,
57-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Shirayama, M.,
Kawakami, K.,
Matsui, Y.,
Tanaka, K.,
and Toh-e, A.
(1993)
Mol. Gen. Genet.
240,
323-332[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Lee-Yoon, D.,
Easton, D.,
Murawski, M.,
Burd, R.,
and Subjeck, J. R.
(1995)
J. Biol. Chem.
270,
15725-15733[Abstract/Free Full Text]
|
| 41.
|
Storozhenko, S.,
De Pauw, P.,
Kushnir, S.,
Van Montagu, M.,
and Inze, D.
(1996)
FEBS Lett
390,
113-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Yasuda, K.,
Nakai, A.,
Hatayama, T.,
and Nagata, K.
(1995)
J. Biol. Chem.
270,
29718-29723[Abstract/Free Full Text]
|
| 43.
|
Chung, K. S.,
Hoe, K. L.,
Kim, K. W.,
and Yoo, H. S.
(1998)
Gene (Amst.)
210,
143-150[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Plesofsky-Vig, N.,
and Brambl, R.
(1998)
J. Biol. Chem.
273,
11335-11341[Abstract/Free Full Text]
|
| 45.
|
Santos, B. C.,
Chevaile, A.,
Kojima, R.,
and Gullans, S. R.
(1998)
Am. J. Physiol.
274,
F1054-F1061
|
| 46.
|
Oh, H. J.,
Chen, X.,
and Subjeck, J. R.
(1997)
J. Biol. Chem.
272,
31636-31640[Abstract/Free Full Text]
|
| 47.
|
Brodsky, J. L.,
Werner, E. D.,
Dubas, M. E.,
Goeckeler, J. L.,
Kruse, K. B.,
and McCracken, A. A.
(1999)
J. Biol. Chem.
274,
3453-3460[Abstract/Free Full Text]
|
| 48.
|
Wach, A.,
Brachat, A.,
Pohlmann, R.,
and Philippsen, P.
(1994)
Yeast
10,
1793-1808[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Nicolet, C. M.,
and Craig, E. A.
(1989)
Mol. Cell. Biol.
9,
3638-3646[Abstract/Free Full Text]
|
| 50.
|
Nicolet, C. M.,
and Craig, E. A.
(1991)
Methods Enzymol.
194,
710-717[Medline]
[Order article via Infotrieve]
|
| 51.
|
Dolinski, K. J.,
Cardenas, M. E.,
and Heitman, J.
(1998)
Mol. Cell. Biol.
18,
7344-7352[Abstract/Free Full Text]
|
| 52.
|
Stebbins, C. E.,
Russo, A. A.,
Schneider, C.,
Rosen, N.,
Hartl, F. U.,
and Pavletich, N. P.
(1997)
Cell
89,
239-250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Panaretou, B.,
Prodromou, C.,
Roe, S. M.,
O'Brien, R.,
Ladbury, J. E.,
Piper, P. W.,
and Pearl, L. H.
(1998)
EMBO J.
17,
4829-4836[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Bohen, S. P.
(1998)
Mol. Cell. Biol.
18,
3330-3339[Abstract/Free Full Text]
|
| 55.
|
Nathan, D. F.,
Vos, M. H.,
and Lindquist, S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12949-12956[Abstract/Free Full Text]
|
| 56.
|
Cyr, D. M.,
and Neupert, W.
(1996)
in
Stress-inducible Cellular Responses
(Feige, U.
, Morimoto, R. I.
, Yahara, I.
, and Polla, B. S., eds)
, pp. 25-40, Birkhauser Verlag, Boston
|
| 57.
|
Pfund, C.,
Lopez-Hoyo, N.,
Ziegelhoffer, T.,
Schilke, B. A.,
Lopez-Buesa, P.,
Walter, W. A.,
Wiedmann, M.,
and Craig, E. A.
(1998)
EMBO J.
17,
3981-3989[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Minami, Y.,
Kawasaki, H.,
Suzuki, K.,
and Yahara, I.
(1993)
J. Biol. Chem.
268,
9604-9610[Abstract/Free Full Text]
|
| 59.
|
Sorger, P. K.,
and Pelham, H. R. B.
(1988)
Cell
54,
855-864[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Kimura, Y.,
Matsumoto, S.,
and Yahara, I.
(1994)
Mol. Gen. Genet.
242,
517-527[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. L. Hrizo, V. Gusarova, D. M. Habiel, J. L. Goeckeler, E. A. Fisher, and J. L. Brodsky
The Hsp110 Molecular Chaperone Stabilizes Apolipoprotein B from Endoplasmic Reticulum-associated Degradation (ERAD)
J. Biol. Chem.,
November 9, 2007;
282(45):
32665 - 32675.
[Abstract]
[Full Text]
[PDF]
|
 |
|